ZURICH, Aug. 6, 2024 /PRNewswire/ —
The Adecco Group Half Year Report 2024 is now available in the Ad Hoc section of the Group’s website, which is directly accessible by clicking here.
Investor Relations:
+41 (0)44 878 88 88
Logo – https://healthtechnologynet.com/wp-content/uploads/2024/08/The_Adecco_Group_Logo.jpg
SOURCE The Adecco Group
ATLANTA, GA AND DOHA, QATAR / ACCESS Newswire / December 6, 2025 / Ameerex Corporation…
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…